| ²é¿´: 345 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
С²Ý_ÏÊ»¨Ð³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇóÖúһƪÎÄÕ£ºCharacterization of human ovarian carcinoma-associated antigens ÒÑÓÐ1È˲ÎÓë
|
||
| Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity |
» ²ÂÄãϲ»¶
ºþ±±Ê¦·¶´óѧ¸´ÊÔµ÷¼Á
ÒѾÓÐ0È˻ظ´
Î人·ÄÖ¯´óѧ_»¯¹¤Ñ§Ôº¹Ù·½µ÷¼ÁȺ-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸß-ÿ½ì·¢Õ¹ºÃ
ÒѾÓÐ0È˻ظ´
ÎÞ»ú»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ286È˻ظ´
¼ÃÄÏ´óѧ¹ú¼ÒÓÅÇà¿ÎÌâ×é 2026 µ÷¼ÁÕÐÉúÀ´À²
ÒѾÓÐ0È˻ظ´
Î人·ÄÖ¯´óѧ_»¯Ñ§Ôº¹Ù·½µ÷¼ÁȺ-ԺʿÍŶÓÕÐÉú-ѧÉú×ÔÓɶȸ߷¢Õ¹ºÃ-»¶Ó¸÷λͬѧ
ÒѾÓÐ0È˻ظ´
ºÓ±±´óѧ ²ÄÁÏÓ뻯¹¤ ˶ʿÕÐÊÕµ÷¼Á
ÒѾÓÐ0È˻ظ´
Î÷»ª´óѧ »¯Ñ§ µ÷¼ÁÓÐÃû¶î
ÒѾÓÐ0È˻ظ´
ÉϺ£Ó¦Óü¼Êõ´óѧÕÐÉúµ÷¼ÁÑо¿Éú
ÒѾÓÐ2È˻ظ´
huaiji
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 11943.6
- ºì»¨: 5
- Ìû×Ó: 884
- ÔÚÏß: 292.1Сʱ
- ³æºÅ: 1540206
- ×¢²á: 2011-12-16
- ÐÔ±ð: GG
- רҵ: ÀíÂۺͼÆË㻯ѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
| ÎÄÏ×Òѵõ½£¬Çë²éÊÕ£¡ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : CHARACTERIZATIONOFHUMANOVARIANCARCINOMA-ASSOC.pdf
2014-04-02 20:59:21, 1018.68 K

3Â¥2014-04-02 20:59:31
huaiji
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 11943.6
- ºì»¨: 5
- Ìû×Ó: 884
- ÔÚÏß: 292.1Сʱ
- ³æºÅ: 1540206
- ×¢²á: 2011-12-16
- ÐÔ±ð: GG
- רҵ: ÀíÂۺͼÆË㻯ѧ

2Â¥2014-04-02 07:52:51














»Ø¸´´ËÂ¥